To elucidate the molecular basis of oculocutaneous albinism with variable expressivity in a family from The Netherlands in which no consanguinity was reported. Three affected family members were screened for mutations in tyrosinase (TYR) and the pink-eye-
Plomp, Astrid S. +6 more
core
Cataract surgery with implantation of small aperture acrylic hydrophobic IOL to reduce photophobia in a patient affected by oculocutaneous albinism. [PDF]
Mularoni A +7 more
europepmc +1 more source
A Dosage-Dependent Dominant-Negative Mechanism of SLC45A2(W74R) in Autosomal Dominant Oculocutaneous Albinism Revealed by Zebrafish Modeling. [PDF]
Surl D +10 more
europepmc +1 more source
Trichilemmal Carcinoma in a Patient With Oculocutaneous Albinism. [PDF]
Theriot T, Joseph JM, Falgout L, Haas C.
europepmc +1 more source
Genetic Diagnosis of Oculocutaneous Albinism Type 1A: A Novel <i>TYR</i> Variant. [PDF]
Shihab RN +5 more
europepmc +1 more source
Generation and ophthalmological characterization of oculocutaneous albinism type 1 pig models by selection-free genome editing. [PDF]
Oh D +14 more
europepmc +1 more source
Genetic analyses of Vietnamese patients with oculocutaneous albinism. [PDF]
Thuong MTH +8 more
europepmc +1 more source
Oculocutaneous albinism in a patient with an <i>OCA2</i> variant: molecular and clinical insights. [PDF]
Neissi M +6 more
europepmc +1 more source
Identification of a RAB32-LRMDA-Commander membrane trafficking complex reveals the molecular mechanism of human oculocutaneous albinism type 7. [PDF]
Butkovič R +12 more
europepmc +2 more sources
Low-vision intervention for oculocutaneous albinism in a Tertiary Eye Care Hospital in India. [PDF]
Gopalakrishnan S +4 more
europepmc +1 more source

